CoChat

The Oral Minimal Model Method

Open access
Cobelli, Claudio, Dalla Man, Chiara, Toffolo, Gianna, Basu, Rita, Vella, Adrian, Rizza, Robert · 2014 · Diabetes

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

The simultaneous assessment of insulin action, secretion, and hepatic extraction is key to understanding postprandial glucose metabolism in nondiabetic and diabetic humans. We review the oral minimal method (i.e., models that allow the estimation of insulin sensitivity, β-cell responsivity, and hepatic insulin extraction from a mixed-meal or an oral glucose tolerance test). Both of these oral tests are more physiologic and simpler to administer than those based on an intravenous test (e.g., a glucose clamp or an intravenous glucose tolerance test). The focus of this review is on indices provided by physiological-based models and their validation against the glucose clamp technique. We discuss first the oral minimal model method rationale, data, and protocols. Then we present the three minimal models and the indices they provide. The disposition index paradigm, a widely used β-cell function metric, is revisited in the context of individual versus population modeling. Adding a glucose tracer to the oral dose significantly enhances the assessment of insulin action by segregating insulin sensitivity into its glucose disposal and hepatic components. The oral minimal model method, by quantitatively portraying the complex relationships between the major players of glucose metabolism, is able to provide novel insights regarding the regulation of postprandial metabolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db13-1198

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Net SI (i.e., insulin action on glucose disposal and production) versus SID (i.e., insulin action on glucose disposal only from IVGTT data).
Figure 1 Net SI (i.e., insulin action on glucose disposal and production) versus SID (i.e., insulin action on glucose disposal only from IVGTT data).CC BY-NC-ND · PubMed Central
Figure 2 Top: MTT (left) and OGTT (right) plasma glucose (top), insulin (middle), and C-peptide (bottom) in the same subject. Bottom: Partition analysis of the system allows us to separately estimate SI, β-cell responsivity, and hepatic extraction without the confounding effect of the two other parameters. Relevant input and output signals of the three models are shown.
Figure 2 Top: MTT (left) and OGTT (right) plasma glucose (top), insulin (middle), and C-peptide (bottom) in the same subject. Bottom: Partition analysis of the system allows us to separately estimate SI, β-cell responsivity, and hepatic extraction without the confounding effect of the two other parameters. Relevant input and output signals of the three models are shown.CC BY-NC-ND · PubMed Central
Figure 3 The oral glucose minimal models that allow us to estimate SI (top), β-cell responsivity (middle), and hepatic insulin extraction (bottom).
Figure 3 The oral glucose minimal models that allow us to estimate SI (top), β-cell responsivity (middle), and hepatic insulin extraction (bottom).CC BY-NC-ND · PubMed Central
Figure 4 Schematic diagram to illustrate the importance of expressing β-cell responsivity in relation to SI by using the DI metric (i.e., the product of β-cell responsivity times SI is assumed to be a constant). Left: A normal subject (state I) reacts to impaired SI by increasing β-cell responsivity (state II), while a subject with impaired tolerance does not (state 2). In state II, β-cell responsivity is increased but the DI is unchanged, and normal glucose tolerance is retained normal; while in state 2, β-cell responsivity is normal but not adequate to compensate the decreased SI (state 2), and glucose intolerance is developed. Right: Impaired glucose tolerance can arise due to defects of β-cell responsivity and/or defects of SI. In this hypothetical example, subject x is intolerant due to his poor β-cell function, while subject y has poor SI. The ability to dissect the underlying physiological defects (SI or β-cell responsivity) allows us to optimize medical treatments.
Figure 4 Schematic diagram to illustrate the importance of expressing β-cell responsivity in relation to SI by using the DI metric (i.e., the product of β-cell responsivity times SI is assumed to be a constant). Left: A normal subject (state I) reacts to impaired SI by increasing β-cell responsivity (state II), while a subject with impaired tolerance does not (state 2). In state II, β-cell responsivity is increased but the DI is unchanged, and normal glucose tolerance is retained normal; while in state 2, β-cell responsivity is normal but not adequate to compensate the decreased SI (state 2), and glucose intolerance is developed. Right: Impaired glucose tolerance can arise due to defects of β-cell responsivity and/or defects of SI. In this hypothetical example, subject x is intolerant due to his poor β-cell function, while subject y has poor SI. The ability to dissect the underlying physiological defects (SI or β-cell responsivity) allows us to optimize medical treatments.CC BY-NC-ND · PubMed Central
Figure 5 The oral-labeled minimal models. Left: The exogenous glucose model. Right: The endogenous glucose model.
Figure 5 The oral-labeled minimal models. Left: The exogenous glucose model. Right: The endogenous glucose model.CC BY-NC-ND · PubMed Central
Figure 6 Left: SID, MTT versus clamp. Right: SIL, MTT versus clamp.
Figure 6 Left: SID, MTT versus clamp. Right: SIL, MTT versus clamp.CC BY-NC-ND · PubMed Central
Figure 7 Net SI (i.e., insulin action on glucose disposal and production) versus SID (i.e., insulin action on glucose disposal only) from MTT data.
Figure 7 Net SI (i.e., insulin action on glucose disposal and production) versus SID (i.e., insulin action on glucose disposal only) from MTT data.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 1

  1. Cobelli, 1999, Minimal model SG overestimation and SI underestimation: improved accuracy by a Bayesian two-compartment model, Am J Physiol, 277, E481

Cited by

Metadata

Authors
Cobelli, C., Dalla Man, C., Toffolo, G., Basu, R., Vella, A., & Rizza, R.
Affiliations
  • University of Padua (IT)
  • Department of Information Engineering, University of Padova, Padova, Italy
  • Mayo Clinic (US)
Corresponding author
Cobelli, Claudio
Venue
Diabetes
Published
2014-03-13
Volume
63
Issue
4
Pages
1203-1213
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2123229781
Cited by
216
References
47
Citations by year
2026: 12 · 2025: 15 · 2024: 16 · 2023: 23 · 2022: 16 · 2021: 18 · 2020: 19 · 2019: 19 · 2018: 22 · 2017: 17 · 2016: 18 · 2015: 13 · 2014: 8
FWCI
3.52
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by-nc-nd)
Funders
  • National Institutes of Health (UL1TR000135)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK029953, P30DK050456, DK 29953, R37DK029953)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
insulin sensitivity, beta-cell function, hepatic insulin extraction, postprandial glucose metabolism, oral glucose tolerance test, mixed meal tolerance test, disposition index, glucose tracer, glucose disposal
MeSH terms
Adolescent, Blood Glucose, C-Peptide, Child, Food, Glucose, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Liver, Models, Biological, Glucose Clamp Technique, Postprandial Period, Insulin-Secreting Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.